Robert Dickey IV, Senior Vice President at HEMISPHERX BIOPHARMA INC (HEB), bought 2,500 shares at $0.64 ($2K) on 2009-12-08, disclosed to the SEC on 2009-12-08.
Open-market purchase of $2k HEB by Senior Vice President. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.